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ABSTRACT
Background/rationale: Patient safety is a major
concern in healthcare systems worldwide. Although
most safety research has been conducted in the
inpatient setting, evidence indicates that medical errors
and adverse events are a threat to patients in the
primary care setting as well. Since information about
the frequency and outcomes of safety incidents in
primary care is required, the goals of this study are to
describe the type, frequency, seasonal and regional
distribution of medication incidents in primary care in
Switzerland and to elucidate possible risk factors for
medication incidents.
Methods and analysis: Study design and setting:
We will conduct a prospective surveillance study to
identify cases of medication incidents among primary
care patients in Switzerland over the course of the year
2015. Participants: Patients undergoing drug treatment
by 167 general practitioners or paediatricians reporting
to the Swiss Federal Sentinel Reporting System.
Inclusion criteria: Any erroneous event, as defined by
the physician, related to the medication process and
interfering with normal treatment course. Exclusion
criteria: Lack of treatment effect, adverse drug
reactions or drug–drug or drug–disease interactions
without detectable treatment error. Primary outcome:
Medication incidents. Risk factors: Age, gender,
polymedication, morbidity, care dependency,
hospitalisation. Statistical Analysis: Descriptive
statistics to assess type, frequency, seasonal and
regional distribution of medication incidents and
logistic regression to assess their association with
potential risk factors. Estimated sample size: 500
medication incidents. Limitations: We will take into
account under-reporting and selective reporting among
others as potential sources of bias or imprecision
when interpreting the results.
Ethics and dissemination: No formal request was
necessary because of fully anonymised data. The
results will be published in a peer-reviewed journal.
Trial registration number: NCT0229537.
INTRODUCTION
Patient safety is a major concern in healthcare
systems worldwide. Although most safety
research has been conducted in the inpatient
setting,1 evidence indicates that medical
errors and adverse events pose a serious
threat for patients in the primary care setting
as well, since most patients receive ambulatory
care.2–4 Gandhi and Lee5 noted that safety
concerns in the outpatient setting differ from
those in the hospital setting in obvious and
non-obvious ways. Medication-related inci-
dents are also important in primary care, but
are perhaps not as well documented as in sec-
ondary care. A study by Gandhi and Lee6 in
primary care showed that 25% of 661 ambula-
tory care patients with at least one prescrip-
tion had such an incident, of which 13% were
classiﬁed as serious and 39% as preventable
or ameliorable. In a study by Pirmohamed
et al in the UK, medication-related incidents
caused about 6.8% of all hospitalisations7 and
in Switzerland, these incidents are respon-
sible for about 7.2% of hospitalisations.8
Diagnostic errors9 and adverse drug events
have been identiﬁed as frequent safety con-
cerns; furthermore, there is a body of litera-
ture about the safety of outpatient procedures
and the consequences of coordination as well
as continuity-of-care failures.10 Hospital and
outpatient care also differ in their infrastruc-
ture and in many processes, as well as in their
ability to detect, monitor and address safety
issues. Information about the frequency and
outcomes of safety incidents in primary care
is required to identify risks or ‘hot spots’, to
prioritise them and to take action as needed.
Strengths and limitations of this study
▪ First Swiss prospective and systematic collection
of incident data in primary care.
▪ Covering three linguistic regions and two distri-
bution systems.
▪ Bias from selective and under-reporting or
non-detection.
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Definition of terms
For the purpose of our study, we use the terminology of
the International Classiﬁcation for Patient Safety
(WHO).11 Here, a patient safety incident is deﬁned as an
event or a circumstance which could have resulted or did
result in unnecessary harm to a patient. There are several
possible causes. (1) An error, deﬁned as: failure to carry
out a planned action as intended or an application of an
incorrect rule; (2) A violation, deﬁned as: deliberate devi-
ation from an operating procedure, standard or rule; (3)
An (external) circumstance, deﬁned as: a situation or
factor that may inﬂuence an event, agent or person. We
want to distinguish incidents from adverse drug reactions
(ADR) which are deﬁned as: unexpected harm resulting
from a justiﬁed action where the correct medication
process was followed for the context in which the event
occurred. The same applies to drug–drug or drug–disease
interactions (DDI). Critical Incident Reporting System (CIRS)
refers to a voluntary anonymous database system to which
Swiss family physicians or paediatricians may report inci-
dents as those occurred in their practices.
We will restrict the topic of our study to medication-
related incidents. Medication or medicine refers to a
pharmaceutical drug, ofﬁcially called a medicinal
product, which can be loosely deﬁned as any chemical
substance—or product comprising such—intended for
use in the medical diagnosis, cure, symptomatic treat-
ment, or prevention of disease (Wikipedia).
Information retrieval
Methods to collect information about adverse incidents
are manifold.2 11–14 In the literature, different ways to
collect adverse incident information are described: volun-
tary versus mandatory reporting systems, patient question-
naires, or pharmacists reporting to registries. Interviews
can be held with physicians or questionnaires can be ﬁlled
out by them. Charts of deceased patients can be audited
meticulously or medicolegal cases may be analysed.
Information may be derived prospectively in an actual case
by case manner or retrospectively along case vignettes.
The two methods most commonly used are incident
reporting and chart review. Both methods have the poten-
tial to systematically cover information on the entire range
of safety events in medical ofﬁces in common.
Incident reporting has a long tradition in clinical risk man-
agement and is increasingly used in outpatient care.15–18
Indeed, incident reporting has been the dominant
method for the study of safety incidents in primary care.19
It is based on voluntary and usually anonymous reports of
physicians and nurses, and is used to describe the types
and characteristics of patient safety incidents. These
reports may vary considerably with respect to the informa-
tion which is included and the likelihood of ‘true’ inci-
dents being reported is unclear. Studies based on this
method describe large variations in the number of reports
submitted.20 Moreover, professional groups differ in their
frequency of reporting; in-hospital care physicians
reported preferentially severe incidents, while nurses cover
the whole spectrum of impact levels.20 Selective reporting
by physicians may have multifactorial causes such as lack of
time, thinking that an ADR which is already known is not
worth mentioning, or concerns about data conﬁdentiality.
Non-reporting may be as frequent as 94%.21 22 O’Beirne
et al concluded from a very low report rate (<1 report per
person per year) that incident reporting may be “a costly
but not very effective way to study safety problems in
primary care”.23 A recent Swiss study analysed safety issues
in primary care.12 This was a semiquantitative, retrospect-
ive investigation involving over 300 nurses and physicians.
Seven of 23 issues were related to drug treatment.
Frequently named issues were insufﬁcient monitoring of
potential side effects, missing prescriptions of required
treatment, and errant medication relating to the route of
administration, dosage or timing. The low and perhaps,
selective reporting of incidents in any system makes it difﬁ-
cult or virtually impossible to collect valuable quantitative
information from CIRS.24
In chart review, medical records are analysed by inde-
pendent experts in order to identify adverse events, and
to assess potential harm and preventability in each
case.25 Such analysis requires complete and correct
patient documentation to provide valid results. In many
cases relevant information may be unavailable.25 As
chart review is a time-consuming approach, many
resources are needed to analyse a large number of
patient records at different primary care ofﬁces; further-
more, this kind of analysis is usually retrospective.
Sandars and Esmail2 described a frequency of 5–80
medical errors per 100 000 consultations in primary care
patients. Incidents, as deﬁned above, may also result from
circumstantial factors (without any errors) and therefore,
occur somewhat more frequently. In order to not over-
burden the participating physicians with our study, we
decided to limit our focus to medication incidents. These
make up between 9% and 42% of all registered inci-
dents2 9 26–28 and of these, approximately 70% may be
prescription errors.29 In contrast to the study by Sandars
and Esmail, our pilot study found a rate of approximately
one medication incident per 2 months and per physician
(see online supplementary appendix 1), while the
former reported a rate of about one in 2 years.
Concerning predisposing factors, Avery et al30 found a
propensity for becoming a victim of medication errors
with the young (<15 years) or elderly (>64 years) ages.
The latter was conﬁrmed by Salanitro et al.31 Two studies
by Field et al32 33 reported morbidity as promoting
errors. All studies listed polymedication as a key
factor.30–34 Better knowledge of factors associated with
medication errors would be helpful to implement pre-
ventive measures and therefore, reduce the frequency of
avoidable incidents in the future.
The Swiss National Sentinel Reporting Network
(http://www.sentinella.ch)
To apply a supplementary method to gaining insight into
safety hot spots in primary care, we aim to assess
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medication errors by using the Swiss National Sentinel
Reporting Network. Founded in 1986, it was mainly designed
to survey transmissible diseases. Later, it also assessed
other health problems of public interest. In 2015, besides
our project, the areas covered are: surveillance of mumps,
whooping cough, ﬂu or Borrelia, pneumonia and middle
ear infections, tick bites, vaccinations against measles or
whooping cough, and alcohol use among adolescents.
One hundred and forty general internal medicines and 27
paediatric practices report to the system, 109 of them in
the German, 44 in the French, and 14 in the Italian part
of Switzerland. It generates daily to weekly current data
and covers the entire geographic and linguistic regions of
our country.
METHOD
Aims of the project
To describe the type, frequency, seasonal and regional
distribution of medication incidents in primary care in
Switzerland and to elucidate possible risk factors such as
age, gender, polymedication, morbidity, and previous
hospitalisation.
Study design
We will conduct a prospective surveillance study to iden-
tify cases of medication incidents among primary care
patients over the course of 1 year.
Population
Any person undergoing drug treatment in general
internal or paediatric practices participating in the
Sentinella network. The latter covers a representative
sample of patients in primary care for Switzerland (see
above). These patients include children, individuals with
mental retardation or the elderly—all of whom might be
at increased risk for medication errors.
Inclusion criteria
▸ Any erroneous event (as deﬁned by the physician)
relating to the medication process and interfering
with the normal treatment course.
Exclusion criteria
▸ Lacking treatment effect, ADR, or drug–drug inter-
action or DDI without detectable treatment error.
▸ Refusal of patients to refer data to the Sentinel system.
Questionnaire development
As we could not identify questionnaires suitable for con-
tinuous reporting and adaptable to our local conditions,
we had to develop new ones. We tested these in an
8-week pilot study (see online supplementary
appendix 1).
In the Sentinella study, the Italian speaking physicians had
to decide whether to report in German or French. For the
main study, we developed only two language sets of question-
naires, since these had to be ﬁlled in only by physicians, not
by patients. We deemed assessment of construct validity of
the questionnaires not imperative, since we did not measure
hidden constructs (like ‘depression’) by our questions and
information was mainly needed about inﬂuencing our
target variable, that is, the type and frequency of incidents.
Data to be collected
The data to be collected in our study are summarised in
boxes 1 (physician related) and 2 (patient related/inci-
dent related); for the latter, only pre-existing data from
medical records will be collected. Furthermore, we col-
lected denominator data as depicted in box 3.
Time schedule
The pilot study took place from July until September 2013.
The ﬁnal questionnaires in both languages and their
English translation are available at http://www.
medication-incidents.ch. The main study takes place from
January until December 2015. Evaluation of the study data
and writing of the publication will be performed in 2016.
Statistics
Expected number of cases
On the basis of our pilot trial (see online supplementary
appendix), we expect at least one drug-related incident
to be reported every 2 months per physician. In the
Sentinella system, there are currently 167 physicians
actively reporting, among them are 27 paediatricians.
Box 1 Physician-related data
Initial questionnaire
Sentinella identification number
Gender*
Age*
Specialisation (general practitioner or paediatrician)*
Number of physicians in practice, and among them those report-
ing to Sentinella*
Working hours per week*
Drug distribution system (by pharmacist or by physician)
Drug prescription system (electronic, machine written,
hand-written)
Electronic drug–drug interaction (DDI) system
Availability of X-ray, ECG, ultrasound
Medical history (electronic or paper based)
Quality certificate
Team sessions
Physician’s participation in quality circle
Localisation (urbanity, language region)*
Special education/interests
Caring for institutions
Final questionnaire
Proportion of non-reporting incidents during the study
The data are collected from each physician reporting to the
Sentinella system. The questionnaire and the coding plan are
available at http://www.medication-incidents.ch.
*These data is delivered by Sentinella administration. All other
data will be collected by use of questionnaires.
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When assuming that they work 10 months per year, this
would result in 660 reported incidents. We, hence, have
to decrease this number to some extent because not all
physicians work 100%, there will be some non-reporting
or non-detection of incidents, and paediatricians report
lower rate of incidents (according to the results of our
Box 2 Patient-related data
Patient-related/incident-related items
Week of reporting
Year of birth
Gender
Physician-to-patient relationship
Dwelling situation
Social problems
Dementia or learning disabilities
Psychiatric problems
Use of psychotropic drugs
Linguistic problems
Smoking or substance abuse
Visual blurring or hearing loss
Gait disturbance
Renal insufficiency
Liver cirrhosis/insufficiency
Previous hospitalisation (12 months)
Care dependency
Number of chronically administered active drugs*
Number of diagnoses for chronic disease
Scale value of ‘Thurgau Morbidity Index’ (TMI)35
Description of incident
Who noticed the incident
What went wrong
Name of drug
Other drugs used possibly related to the incident
Endangering of patient
Amount of damage
Organ system involved
Duration
Recovery
Treatment/surveillance
Causal triggers
Interface problems
Information to the patient about the incident and his reaction
Consequences of the incident
Responsibility
Possibility to anticipate the incident
Whether a similar incident was previously notified within the study
General proposals
Physician-related items
Sentinella identification number
The data are collected for each incident. The basic reporting of a medication incident is collected weekly. It includes the Sentinella identifica-
tion number, the gender of the patients and their year of birth. The questionnaire and the coding plan are available at http://www.
medication-incidents.ch.
*Each regularly prescribed or administered pharmacological specialty counts per active substance contained, according to the latest available
medication list. All therapies regularly taken during at least 1 month are considered. Drugs that are prescribed for shorter periods (eg, anti-
biotics for a week) are not included. Regularly administered eye drops, inhalations, nasal sprays count if a general systemic effect is inten-
tional (eg, calcitonin nasal spray) or must be taken into account (eg, timolol eye drops). Also transcutaneous, subcutaneous or vaginal
hormone-releasing systems, and preparations administered by the specialist (eg, gynecologist: birth control pills) should be recorded.
Herbal drugs count—regardless of the number of plants—as one medication. Homeopathic drugs, cell salts, etc, are not counted.
Multivitamins count if they are taken due to a medical indication (eg, short bowel syndrome), but not when the administration was adopted
as ‘roborant’; multivitamins are considered one drug. Also therapies at the hospital administered such as oncology are counted. Whether the
patient also applies the drug (compliance) is irrelevant to the study, the important thing is that it is so prescribed. Prescribed medications to
relieve on requirement which do not need to be taken daily, or self-medication is not recorded.
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pilot study). So we expect approximately 500 incidents
in our study.
Statistical methods
For the analysis of our data, we will use descriptive statistics
in order to describe the type, frequency, seasonal and
regional distribution of medication incidents. We will use
logistic regression to assess the association of medication
incidents with potential risk factors. We will use SPSS.
Independent ethical committee
The ethical committee of Canton Zurich decided that
our study did not need formal approval, because the
data are completely anonymous (KEK-ZH 2014-0400).
The study was recorded in http://www.ClinicalTrials.gov:
NCT02295371, as well as in our national study registry
(http://www.kofam.ch; SNCTP000001207).
STROBE statement: Where applicable, our publication
will follow the general STROBE guidelines (http://www.
equator-network.org/).
RESULTS FROM A PILOT STUDY
From the existing literature,12 we included questions on
the social and clinical state of the patients, on the type of
incident, and on possible causative factors, and tested
these in a pilot study, from July until September 2013, with
a sample of general physicians or paediatricians; these
were in two language sets (German and French) for the
three different language regions of Switzerland (German
11, French 7, Italian 3) for 8 weeks. Fifty-one cases were
recorded, leading to an incident rate of 0.4 (median, IQR
0.4) per family physician, and week or 4 (5) per family
physician and 1000 patient contacts. Virtually no incidents
were observed by paediatricians (details of this study are
presented in online supplementary appendix 1).
DISCUSSION
Strength and limitations
Our study is the ﬁrst prospective and systematic collec-
tion of incident data in Swiss primary care. The well-
motivated reporting physicians, the duration of
12 months and the coverage of the three main linguistic
regions as well as of two drug distribution systems will
deliver new and relevant insights.
Not all cases may be reported; there may be some
selective reporting of cases of higher clinical importance,
and some cases may not be reported due to lack of time
or legal considerations. Some cases may not be detected
by the physicians. Some non-prescription treatments may
be missed if they are not causally linked to the incident.
The sample size may be too small for inferential statistics.
The 14-day denominator period may not be representa-
tive for the patient collective over the whole year. The def-
inition of inclusion criteria may be interpreted varyingly
by the physicians. Qualitative information may be missed
in this study and has perhaps to be further addressed in
qualitative research. The low and perhaps selective
reporting of incidents in any system makes it difﬁcult or
virtually impossible to collect valuable quantitative infor-
mation from CIRS.24
CONCLUSION
Data on safety issues in ambulatory primary care patients is
scarce and this is also true for Switzerland. The retrospect-
ive qualitative study by Gehring et al12 and the study by
Livio et al8 on hospitalisations makes it reasonably clear
that things are in no way better than that in UK7 or USA,6
where 6.5% of all hospitalisations and 4.0% of all hospital
care days as well as 1 in 667 hospital deaths are caused by
medication incidents. Since up to 72% of these appear to
be preventable or ameliorable, it seems worthwhile to
focus on these so as to further elucidate risk factors.
The data of our study should allow for describing the
type, frequency, seasonal and regional distribution of
medication incidents in Swiss primary care practices and
for helping to identify risk factors. The deﬁnition of ‘hot
spots’ could sensitise the physicians to focus on danger-
ous situations and help them to redeﬁne their standing
operational procedures (SOPs).
Author affiliations
1Institute of Primary Care, University of Zurich, Zurich, Switzerland
2Department of Clinical Pharmacology and Toxicology, University Hospital
Zurich, Zürich, Switzerland
3National Poisons Centre, Tox Info Suisse, Associated Institute of the
University of Zurich, University Hospital Zurich, Zürich, Switzerland
4Patientensicherheit Schweiz, Zürich, UK
5Policlinique Médicale, University of Lausanne, Lausanne, UK
6Epidemiology, Biostatistics, and Prevention Institute, University of Zurich,
Zürich, Switzerland
7Sentinel Surveillance Network, Swiss Federal Office of Public Health, Bern,
Switzerland
Acknowledgements The authors are grateful to Lee Wennerberg for English
language corrections, the Federal Health Agency for the translation of their
Box 3 Denominator data
Fortnight analysis (only once in study, from 7 to 20 March 2015)
Previous hospitalisation (during the preceding year)
Care dependency
Number of active drugs chronically administered
Number of chronic diagnoses
Scale value of ‘Thurgau Morbidity Index’ (TMI)35
Year of birth*
Gender*
Multiple consultation (within the 14-day period)
Sentinella identification number
Daily analysis
Physician-to-patient contacts
Sentinella identification number
The data are collected from each patient consulting the practice
during the year 2015, irrespective of the presence of an incident.
*Year of birth and gender will be collected during another 14-day
period in fall but without the other items. The questionnaire and
the coding plan are available at http://www.medication-incidents.
ch. Definition of medication count: see box 2.
Gnädinger M, et al. BMJ Open 2015;5:e007773. doi:10.1136/bmjopen-2015-007773 5
Open Access
pilot study questionnaires into French, Dr Sven Staender, Männedorf, for the
helpful comments. They thank all colleagues participating in the pilot study
(Banderet HR, Bigler M, Dafflon M, Ebnöther S, Ferrazzini G, Frey J, Fröhlich
F, Haftgoli N, Köhler B, Marty F, Mühlemann N, Merz A, Oppliger S, Pasche O,
Pilet F, Quack C, Sébo P, Schwarzenbach HR, Spirig M, Valentin J).
Contributors MG lead the study, did the pilot study (questionnaire
development, data entering and processing), wrote all documents, made all
the contacts with the Sentinella administration, ethics committee and others,
programmed the electronic questionnaires, will enter the hand-written
questionnaires into the database, will do the data processing and will write
the publication after data collection. LH is French speaking and will help
others to understand the French-printed questionnaires. MP was responsible
for sound methodology. AS conceived the idea for the study. All the authors
have seen all the study documents and contributed intellectually to this
publication. All the authors have contributed to the revision of the draft of this
publication, and approved the submitted version of this publication.
Funding The study was funded by Bangeter-Rhyner Foundation, Basel (grant
number 8472/HEG-DSV).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Manias E. Detection of medication-related problems in hospital
practice: a review. Br J Clin Pharmacol 2012;76:7–20.
2. Sandars J, Esmail A. The frequency and nature of medical error in
primary care: understanding the diversity across studies. Fam Pract
2003;20:231–6.
3. Thomsen LA, Winterstein AG, Søndergaard B, et al. Systematic
review of the incidence and characteristics of preventable adverse
drug events in ambulatory care. Ann Pharmacother
2007;41:1411–26.
4. Miller GC, Britth HC, Valenti L. Adverse drug events in general
practice patients in Australia. Med J Aust. 2006;184:321–4.
5. Gandhi TK, Lee TH. Patient safety beyond the hospital. N Engl J
Med 2010;363:1001–3.
6. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in
ambulatory care. N Engl J Med 2003;348:1556–64.
7. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions
as cause of admission to hospital: prospective analysis of 18820
patients. BMJ 2004;329:15–19.
8. Livio F, Buclin T, Yersin B, et al. Hospitalisations pour effet
indésirable médicamenteux: Recensement prospectif dans un
service d’urgences médicales. Lausanne: Institut Universitaire de
Médecine Sociale et Préventive, 1998 (Raisons de Santé, 23).
9. Schiff GD, Hasan O, Kim S, et al. Diagnostic error in medicine.
Arch Intern Med 2009;169:1881–7.
10. Fröhlich T, Zorina O, Fontana AO, et al. Evaluation of medication
safety in the discharge medication of 509 surgical inpatients using
electronic prescription support software and an extended
operational interaction classification. Eur J Clin Pharmacol
2011;67:1273–82.
11. Runciman W, Hibbert P, Thomson R, et al. Towards an international
classification for patient safety: key concepts and terms. Int J Qual
Health Care 2009;21:18–26.
12. Gehring K, Schwappach DL, Battaglia M, et al. Frequency of and
harm associated with primary care safety incidents. Am J Manag
Care 2012;18:e323–37.
13. Wetzels R, Wolters R, van Weel C, et al. Mix of methods is needed
to identify adverse events in general practice: a prospective
observational study. BMC Fam Pract 2008;9:35.
14. Gaal S, Harman C, Giesen P, et al. Complaints against
family physicians submitted to disciplinary tribunals in the
Netherlands: lessons for patient safety. Ann Fam Med
2011;9:522–7.
15. Rubin G, George A, Chinn DJ, et al. Errors in general
practice: development of an error classification and pilot study of a
method for detecting errors. Qual Saf Health Care 2003;12:443–7.
16. Elder NC, Vonder Meulen M, Cassedy A. The identification of
medical errors by family physicians during outpatient visits. Ann Fam
Med 2004;2:125–9.
17. Makeham MA, Kidd MR, Saltman DC, et al. The Threats to
Australian Patient Safety (TAPS) study: incidence of reported errors
in general practice. Med J Aust 2006;185:95–8.
18. Makeham MA, Dovey S, Runciman WB, et al. Methods and
measures used in primary care patient safety research. Geneva,
Switzerland: World Health Organization, 2008.
19. Makeham MA, Dovey SM, County M, et al. An international
taxonomy for errors in general practice: a pilot study. Med J Aust
2002;177:68–72.
20. Rowin EJ, Lucier D, Pauker SG, et al. Does error and adverse event
reporting by physicians and nurses differ? Jt Comm J Qual Patient
Saf 2008;34:537–45.
21. Hazell L, Shakir SA. Under reporting of adverse drug reactions:
a systematic review. Drug Saf 2006;29:385–96.
22. Gnädinger M, Mellinghoff HU. The out-of-focus bias in drug
surveillance. Eur J Clin Pharmacol 2013;69:357–9.
23. O’Beirne M, Sterling PD, Zwicker K, et al. Safety incidents in family
medicine. BMJ Qual Saf 2011;20:1005–10.
24. Pham JC, Girard T, Pronovost PJ. What to do with
healthcare incident reporting systems? J Public Health Res 2013;
2:e27.
25. Stange KC, Zyzanski SJ, Smith TF, et al. How valid are medical
records and patient questionnaires for physician profiling and health
services research? A comparison with direct observation of patient
visits. Med Care 1998;36:851–67.
26. Gaal S, Verstappen W, Wolters R, et al. Prevalence and
consequences of patient safety incidents in general practice in the
Netherland: a retrospective medical record review study. Implement
Sci 2011;6:37.
27. Wetzels R, Wolters R, van Weel C, et al. Harm caused by adverse
events in primary care: a clinical observational study. J Eval Clin
Pract 2009;15:323–7.
28. Khoo EM, Lee WK, Saraks S, et al. Medical errors in primary
care clinics—a cross sectional study. BMC Fam Pract
2012;13:127.
29. Kuo GM, Phillips RL, Graham D, et al. Medication errors reported by
US family physicians and their office staff. Qual Saf Health Care
2008;17:286–90.
30. Avery AJ, Maisoon G, Barber N, et al. The prevalence and
nature of prescribing and monitoring errors in English general
practice: a retrospective case note review. Br J Gen Pract 2013;63:
e534–53.
31. Salanitro AH, Osborn CY, Schnipper JL, et al. Effect of patient- and
medication-related factors on inpatient medication reconciliation
errors. J Gen Intern Med 2012;27:924–32.
32. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug
events among older adults in the ambulatory setting. J Am Geriatr
Soc 2004;52:1349–54.
33. Field TS, Mazor KM, Briesacher B, et al. Adverse drug events
resulting from patient errors in older adults. J Am Geriatr Soc
2007;55:271–6.
34. Mira JJ, Orozco-Beltran D, Perez-Jover V, et al. Physician patient
communication failure facilitates medication errors in older
polymedicated patients with multiple comorbidities. Fam Pract
2013;30:56–63.
35. Fischer JE, Peltenburg M, Kühne R, et al. Der TMI auf dem
Prüfstand: Güte und Probleme der Kostenvorhersage
anhand einfach kodierbarer Patientenmorbidität. Schweizerische
Ärztezeitung 2007;88:1156–65.
6 Gnädinger M, et al. BMJ Open 2015;5:e007773. doi:10.1136/bmjopen-2015-007773
Open Access
